Summary: We present a Bayesian nonparametric approach to modelling and risk assessment in developmental toxicity studies. The primary objective for this dose-response setting is to quantify the relationship between the level of exposure of pregnant laboratory animals to a toxic chemical and the probability of prenatal death or a physiological response for viable fetuses. Hence, the data involve clustered categorical responses, and typically suggest response distributions and dose-response relationships that can not be captured well by standard parametric approaches. The focus of our modelling approach is on the dose-dependent response distributions, which are represented through a nonparametric trinomial mixture model. The nonparametric mixing is built from a dependent Dirichlet process prior with the dependence of the mixing distributions governed by the dose level. The key implication of this modelling strategy is flexible inference for both the response distribution as well as for the dose-response curves associated with the different endpoints, including the capacity of the model to capture non-monotonic dose-response relationships. The practical utility of the methodology is illustrated with data from an experiment on the effects of diethylhexalphthalate, a commonly used plasticizing agent.
Introduction
Developmental toxicity studies investigate birth defects induced by toxic chemicals. In particular, under the standard Segment II developmental toxicity experiment, at each experimental dose level, x i , i = 1, ..., N , a number, n i , of pregnant laboratory animals (dams) are exposed to the toxin. Dam j at dose x i has m ij implants, of which the number of resorptions, that is, undeveloped embryos or very early fetal deaths, and prenatal deaths are recorded as R ij , and the number of live pups at birth with a certain malformation are recorded as y ij . Consequently, the number of viable fetuses for dam j at dose x i is m ij − R ij . Additional continuous outcomes measured on each of the live pups may include body weight and length.
The main objective of developmental toxicity studies is to examine the relationship between the level of exposure to the toxin, which we generically refer to as the dose level, and the probability of the various responses of interest. We focus on the clustered categorical endpoints of embryolethality, that is, non-viable fetuses, and fetal malformation for live pups; thus, the data structure comprises {(m ij , R ij , y ij ) : i = 1, . . . , N ; j = 1, . . . , n i }. The corresponding dose-response curves are defined by the probability of the endpoints across dose levels. Also of interest is quantitative risk assessment, which evaluates the probability that adverse effects may occur as a result of the exposure to the substance. Figure 1 is a motivating data set, available from the National Toxicology Program database, from an experiment that explored the effects of diethylhexalphthalate (DEHP), a commonly used plasticizing agent. The left and middle panels correspond to the endpoints of non-viable fetus, that is, resorption or prenatal death, and malformation, that is, external, visceral or skeletal malformation of a live fetus. The right panel plots the proportions of combined negative outcomes, that is, adding the number of non-viable fetuses and malformations.
Plotted in
The number of dams is 30 for the control group, and 26, 26, 17, and 9 for doses 25, 50, 100, and 150 mg/kg ×1000. The number of implants across all dams and dose levels ranges from 4 to 18, with 25th, 50th, and 75th percentiles equal to 11, 13, and 14, respectively. Particularly noteworthy is the drop in the proportions of malformations, and combined negative outcomes, from dose 0 to 25 mg/kg ×1000, which may correspond to a hormetic dose-response relationship.
Hormesis refers to a dose-response phenomenon characterized by favorable biological responses to low exposures to toxins, and thus by opposite effects in small and large doses. For endpoints involving disease incidence, such as mutation, birth defects or cancer, hormesis results in a Jshaped dose-response curve. Although the possibility of different low dose effects is accepted, the suggestion of positive low dose effect is debated, hence, hormesis remains a controversial concept in the toxicological sciences [e.g., 1].
Notwithstanding the ultimate scientific conclusions, data such as the ones from the DEHP study motivate our modelling framework for the dose-dependent response distributions which enables rich inference for the implied, possibly non-monotonic, dose-response curves. Building flexible modelling for the response distribution is easy to justify for developmental toxicology data, which typically indicate vast departures from parametric models. This can be attributed to the inherent heterogeneity in the data due to the clustering of individuals within a group and the variability of the reaction of the individuals to the toxin. Note also that the typical toxicity experiment discussed above provides information on potentially different dose-response relationships for the distinct endpoints of embryolethality and fetal malformation, and it is thus biologically relevant to jointly analyze the clustered responses. This stands in contrast with the prevailing data structure found in the statistical literature, where the variables involved are the number of implants and the sum of all negative outcomes, as in the right panel of Figure 1 .
We develop a Bayesian nonparametric mixture model for the joint distribution of the number of non-viable fetuses and malformations. We seek mixture modelling for response distributions that are related across doses with the level of dependence driven by the distance between the dose values. To this end, we consider a dependent Dirichlet process (DDP) prior [18] for the dosedependent mixing distributions. Particular emphasis is placed on the choice of the mixture kernel and the DDP prior formulation to ensure an increasing trend in prior expectation for the implied dose-response curves, but without restricting prior realizations to be necessarily monotonic.
This is key for the model's capacity to capture non-standard dose-response relationships. The nonparametric mixture model structure enables flexible inference for the response distributions at any observed dose level. Moreover, the dependence of the DDP prior across dose levels allows inference for the induced dose-response relationships through interpolation and extrapolation over any range of dose values of interest.
The modelling approach developed here extends work for the simpler data setting with combined negative outcomes [10] . To our knowledge, the literature does not include any Bayesian nonparametric approaches to modelling developmental toxicology data with a multicategory response classification. A Bayesian semiparametric model for the combined negative endpoints case, based on a product of Dirichlet process prior, was proposed by [5] , and more recently extended in [19] . Examples of parametric Bayesian hierarchical models for toxicology data with discrete-continuous outcomes include [6] and [8] . Regarding the classical literature, a Dirichlettrinomial model is presented in [2] ; [24] develop an extended Dirichlet-multinomial model with
Weibull dose-response functions; and [21] and [17] use quasi-likelihood and generalized estimating equations, respectively, to fit multinomial models which incorporate overdispersion.
The outline of the paper is as follows. Section 2 develops the DDP mixture model, including model properties and methods for prior specification and Markov chain Monte Carlo posterior inference. In Section 3, we present the application to the analysis of the DEHP data. Section 4 concludes with a summary.
Methods

The modelling approach
Under the Segment II toxicity study design, exposure occurs after implantation, and thus it is natural to treat the number of implants as a random quantity containing no information about the dose-response relationship. Hence, the modelling for the number of implants (m), the number of non-viable fetuses (R), and the number of malformations (y) is decomposed to
, where only the conditional distribution f (R, y | m) will depend on dose level x. We assume a shifted Poisson distribution for f (m) such that m ≥ 1, although more general distributions can be readily utilized. Inference for the implant distribution is carried out separately from inference for f (R, y | m), and is not discussed further.
To develop a flexible inference framework for risk assessment, we propose a nonparametric mixture model for the dose-dependent conditional distribution of the number of non-viable fetuses and malformations given the number of implants. Specifically, for a generic dose x,
where k(R, y | m; ϕ) is a parametric kernel, with parameters ϕ, and G x the dose-dependent mixing distribution. Placing a nonparametric prior on G x results in a nonparametric mixture prior for f (R, y | m; G x ). Nonparametric Bayesian mixture priors offer flexible modelling tools that, with the appropriate structure, can capture the complexity inherent in the data. These models can be viewed as extensions of finite mixture or continuous mixture models, where the random mixing distribution is not defined with a particular parametric family of distributions.
Regarding the mixture kernel, we take
where π(u) = exp(u)/{1+exp(u)}, u ∈ R, will be used to denote the logistic function. Therefore, π(γ) is the kernel probability of a non-viable fetus, and π(θ) the conditional probability of a malformation for a live pup. This formulation of the trinomial kernel distribution is natural as it highlights the nested nature of the count responses. Moreover, the logistic transformation for the Binomial probabilities is used to facilitate the formulation of the nonparametric prior model for the collection of mixing distributions, G X = {G x : x ∈ X }, where X ⊆ R + .
As discussed in the Introduction, we seek modelling for the response distributions that allows nonparametric dependence structure across dose levels. We achieve such modelling by placing a DDP prior on the dose-dependent mixing distributions {G x : x ∈ X }. The DDP prior arises through extension of the Dirichlet process (DP) prior [9] , the most widely used prior for mixing distributions in nonparametric or semiparametric mixture models. We use DP(α, G 0 ) to denote the DP prior defined in terms of a parametric centering distribution G 0 , and precision parameter
To define the form of the DDP prior we use for G X , the almost sure discrete representation for the regular DP [22] is extended to
where δ a denotes a point mass at a, the η lX = {η l (x) : x ∈ X } are independent realizations from a stochastic process G 0X over X , and the weights are defined by a stick-breaking process:
with ζ l independent from a Beta(1,α) distribution, independently of the η lX . A key feature of the DDP prior is that for any finite collection of dose levels (x 1 , ..., x k ) it induces a multivariate DP prior for the corresponding collection of mixing
. Therefore, the DDP prior model involves a countable mixture of realizations from stochastic process G 0X with weights matching those from the standard DP; this prior structure is referred to as single-p DDP prior. Single-p DDP mixture models have been applied to analysis of variance settings [4] , spatial modelling [11; 15] , dynamic density estimation [20] , quantile regression [16] , and survival regression [3] .
Finally, the DDP prior mixture model is given by
Here, DDP(α, G 0X ) denotes the DDP prior for
, for x ∈ X , with precision parameter α and base stochastic process G 0X . We define G 0X through two independent Gaussian processes, one driving each probability of response, each with a linear mean function, constant variance, and isotropic exponential correlation function. Hence, to introduce notation, we assume for all l,
, with ρ > 0 and φ > 0. As discussed in the next section, this specification for G 0X and, in particular, the linear mean functions, are key for flexible inference about the dose-response relationships implied by model (2) . The full Bayesian model is implemented with priors on α and on the G 0X hyperparameters,
Dose-response relationships
Here, we study the dose-response curves implied by DDP mixture model (2) , including the probability of a non-viable fetus, the conditional probability of a malformation for a live pup, and a risk function that combines the two endpoints.
To develop the dose-response curves, it is useful to note a connection of the mixture model with the clustered Binomial kernels with the model based on products of Bernoullis kernel for the underlying binary responses. That is, for a generic dam at dose level x with m implants, 
where G X is assigned the same DDP prior as the one for model (2) . It is straightforward to show that mixture models (2) and (3) are equivalent with regard to the distribution for (R, y) conditional on m; in particular, the joint moment generating function for ( (3) is equal to the joint moment generating function for (R, y) under model (2), in both cases, conditioning on m. Hence, we can define the dose-response curves under the DDP mixture model (2) working with probabilities of the two endpoints for a generic implant; this involves implicit conditioning on m = 1, which we suppress in the notation below.
The first risk assessment quantity of interest is the probability of embryolethality across effective dose levels, which is defined by
Risk assessment for the malformation endpoint is based on the conditional probability that a generic pup has a malformation given that it is a viable fetus, i.e.,
Moreover, a full risk function at any given dose level can be defined through the combination of the probability of a non-viable fetus and the probability of a live, malformed pup; that is, the combined risk at dose level x is given by
A key aspect of the modelling approach is that it does not force a non-decreasing shape restriction to the dose-response functions, which is the traditional assumption for more standard quantal bioassay experiments. As discussed in the Introduction and illustrated in Section 3 with the DEHP data, the model's capacity to capture non-standard, possibly non-monotonic, doseresponse relationships is an asset of the proposed methodology. At the same time, given the relatively small number of observed dose levels in developmental toxicity studies, some structure is needed in the prior model in order to obtain meaningful interpolation and extrapolation posterior inference results for the dose-response curves. Under the specific formulation of the DDP prior for mixture model (2), such structure can be incorporated in the form of a nondecreasing trend in prior expectation for the dose-response curves.
Consider first the prior expectation for the dose-dependent probability of a non-viable fetus,
that is, E{D(x)} is the expectation of the (increasing) logistic function with respect to the
non-decreasing function of x in prior expectation, under the ξ 1 > 0 prior restriction. Similarly, Finally, smoothness properties of prior realizations for the dose-response curves relate directly to the respective properties of the centering process G 0X . For details, we refer to the arguments in [18] and [11] , extended and formalized by [12] , but note briefly that the continuity of the realizations from the two Gaussian processes that define G 0X implies that as the distance between
x and x gets smaller, the difference between G x and G x gets smaller; moreover, it yields continuous prior realizations for the three dose-response functions defined above. The practical implication is that in prediction for the probability mass function f (R, y | m; G x ) and for the corresponding dose-response curves, we learn more from dose levels x nearby x than from more distant doses, a desirable property for distributions that are expected to evolve relatively smoothly with the dose level.
Implementation details
Markov chain Monte Carlo posterior simulation
Regarding the hierarchical model formulation for the data = {(m ij , R ij , y ij ) : i = 1, . . . , N ; j = 1, . . . , n i }, we observe that for the DEHP data (discussed in the Introduction) the dams are labeled and recorded in ascending numerical order across dose levels; that is, the smallest identification number corresponds to data from the first dam at the first dose level, the first dam at the second dose level has the next identification number, and so on. This is also the case for other data sets available from the database of the National Toxicology Program. Therefore, to write the model for the data, the animals are linked as a response vector across the dose levels with the conditional independence assumption built for the replicated response vectors. Hence, the data structure and corresponding hierarchical model is along the lines of the spatial DP [11] rather than, for instance, the ANOVA DDP [4] .
Therefore, let R j = (R 1j , . . . , R Nj ), and y j = (y 1j , . . . , y Nj ) be the j-th response replicates with corresponding number of implants vector m j = (m 1j , . . . , m Nj ), for j = 1, . . . , n, where n = max i n i . Moreover, denote by γ j ≡ γ j (x) = (γ j (x 1 ), . . . , γ j (x N )), and θ j ≡ θ j (x) = (θ j (x 1 ), . . . , θ j (x N )) the latent mixing vector for R j and y j , respectively, where x = (x 1 , . . . , x N ).
We introduce missing value indicators, s ij , such that s ij = 1 if the j-th response replicates at dose level i are present and s ij = 0 otherwise. Note that the s ij are fixed for any particular data set. Then, the first stage of the hierarchical model for the data can be written as Hence, the hierarchical model for the data is a DP mixture model induced by the DDP mixture prior. For Markov chain Monte Carlo posterior simulation, we use blocked Gibbs sampling [e.g., 13], which offers relatively ready implementation and also, in our context, can easily handle unbalanced response replicates. The approach is based on a finite truncation
, where the weights p l arise from a truncated version of the stick-breaking construction:
given ψ, from G 0x , for l = 1, ..., L. Hence, under the truncated version of mixing distribution
To represent the hierarchical model for the data under the DP truncation approximation, configuration variables w = (w 1 , . . . , w n ) are introduced, such that w j = l if and only if (γ j , θ j ) = (U l , Z l ), for l = 1, . . . , L and j = 1, . . . , n. Then, the model for the data can be expressed as
where 
, and the poste-
Here, G γ 0x and G θ 0x denote the respective N -variate normal distributions arising from G 0x . Each of U w * k and Z w * k is updated using a random-walk Metropolis-Hastings step with an N -variate normal distribution as the proposal. The proposal covariance matrices were estimated dynamically, using initial runs based on normal proposals with scaled identity covariance matrices.
The posterior full conditional for each w j , j = 1, ..., n, is given by a discrete distribution with values l = 1, ..., L and corresponding probabilities
The updates for parameters α and p are the same with a generic DP mixture model [14] .
Finally, the joint posterior full conditional for the hyperparameters ψ of the DDP prior centering
Gaussian processes is proportional to
where p(·) denotes the prior for each parameter. The form of G 0x and the parametric priors for the components for ψ result in normal posterior full conditionals for ξ 0 and β 0 , and inverse gamma full conditionals for τ 2 and σ 2 . We use Metropolis-Hastings updates for ξ 1 and β 1 , and sample ρ and φ by discretizing their bounded support.
Inference for risk assessment
The samples from the posterior distribution of model (4) 
Moreover, for a specified number of implants m 0 , the conditional probability mass function for the number of malformations given R 0 non-viable fetuses, is evaluated through
The posterior samples can be summarized with means and percentiles to provide posterior mean estimates and uncertainty bands for dose-response curves and probability mass functions for the response distributions; Section 3 reports such inferences for the DEHP data.
Prior specification
To specify the uniform priors for the range parameters ρ and φ, we consider the limiting case of the DDP model with α → 0 + , which yields the kernel of the mixture in (2) as the model's first stage with G 0X defining Gaussian process priors for the Binomial probabilities on the logistic scale. Then, under the exponential correlation function, 3/ρ is the range of dependence, that is, the distance between dose levels that yields correlation 0.05 for the Gaussian process realizations that define the probability of a non-viable fetus, and, analogously, for 3/φ. The range is usually assumed to be a fraction of the maximum interpoint distance over the index space. Let D max be the maximum distance between observed doses. Since 3/b ρ < 3/ρ, we specify b ρ such that 3/b ρ = rD max for a small r; r = 0.002 was used for the DEHP data analysis in Section 3 leading to a Unif(0, 10) prior for ρ; the same uniform prior was used for φ. This approach to prior specification for ρ and φ is conservative, in particular, the posterior distributions for ρ and φ are concentrated on values substantially smaller than b ρ and b φ .
We set the prior means for ξ 0 and β 0 to 0, and the shape parameters of the inverse gamma priors for τ 2 and σ 2 to 2, implying infinite prior variance. The prior variances for ξ 0 and β 0 , and the prior means for ξ 1 , β 1 , τ 2 and σ 2 are chosen by studying the induced prior distribution for the dose-response curves defined in Section 2. that cover almost the entire unit interval.
The DDP prior precision parameter, α, controls the number, n * , of distinct mixture components [e.g., 7]. In particular, for moderate to large sample sizes, a useful approximation to the prior expectation E(n * | α) is given by α log{(α + n)α −1 }. This expression can be averaged over the prior for α to obtain E(n * ), thus selecting the gamma prior parameters to agree with a guess at the expected number of distinct mixture components. A gamma(2, 1) prior was used for the DEHP data example corresponding to E(n * ) ≈ 5. Prior sensitivity analysis revealed robust posterior inference under more dispersed priors.
Finally, the level L for the DP truncation approximation can be chosen using standard distributional properties for the weights arising from the stick-breaking structure in (1). For 
Data example
We illustrate the proposed DDP mixture modelling approach with the DEHP data set discussed in the Introduction (Figure 1 ). It is known that plasticizers, such as the DEHP plasticizing agent, may leak in small quantities from plastic containers with various solvents such as food or milk. The possibility of toxic effects from these agents have been recognized and tested in developmental toxicity studies such as the one described in [23] . Recall that the two endpoints are non-viable fetus corresponding to resorption or actual prenatal death, and malformation involving external, visceral or skeletal malformation of a live fetus. Figure 3 plots the posterior mean and 90% interval estimates for the three dose-response curves developed in Section 2.2 for risk assessment. The probability of a non-viable fetus across dose levels is a monotonically increasing function, with uncertainty bands around the posterior mean estimate that increase with increasing dose values, consistent with the decreasing number of dams for larger dose levels. The conditional probability of malformation, however, reveals a non-monotonic behavior at the low dose levels, and this J-shaped pattern carries over to the combined risk which also exhibits the dip in the probability from the control through dose 25 mg/kg × 1000. The inference for the combined risk function agrees with the estimated doseresponse curve for the combined negative outcomes version of the DEHP data, as obtained in [10] based on a DDP Binomial mixture model. The modelling approach presented in this paper is key to uncovering the malformation endpoint as the one that contributes to the non-monotonic, possibly hormetic, combined dose-response relationship.
Inference for response distributions is illustrated with posterior mean and 90% interval estimates for the probability mass function of the number of non-viable fetuses given m = 12 implants ( Figure 4 ) and the number of malformations given m = 12 implants and R = 3 nonviable fetuses ( Figure 5 ). Results are reported for the control group, the four effective dose levels, and a new dose at x = 75 mg/kg × 1000. As expected, there is more uncertainty in the estimation of the conditional response distributions for malformation. The interpolation at the new dose level appears to be influenced more by the distribution at dose 50, which can be attributed to the larger sample size relative to dose 100. The estimated distributions for the number of non-viable fetuses have relatively standard shapes, whereas there is some evidence of a bimodal shape at dose 100, and skewness in the estimated malformation distributions.
Summary
We have developed a Bayesian nonparametric modelling approach for risk assessment in developmental toxicity studies. The motivation for the proposed methodology is that it is critical to model flexibly the dose-dependent dam specific response distribution associated with the clustered categorical outcomes of a non-viable fetus and of malformation for a live pup. The model is built from a mixture with a product Binomial kernel, to capture the nested structure of the responses, and a dependent Dirichlet process prior for the dose-dependent mixing distributions.
The resulting nonparametric DDP mixture model provides rich inference for the response distributions as well as for the dose-response curves. Data from a toxicity experiment involving a plasticizing agent were used to illustrate the scientifically relevant feature of the DDP mixture model with regard to estimation of different dose-response relationships for different endpoints, including non-monotonic dose-response curves.
